Resolving arthritis (n = 11) | VeRA (n = 14) | p Value | |
---|---|---|---|
Age, yr | 37.4 ± 10.3 | 52.9 ± 9.5 | 0.001 |
Female, n (%) | 3 (27.3) | 9 (64.3) | <0.0001 |
Disease duration, wk | 4.4 ± 2.9 | 6.1 ± 3.3 | 0.210 |
CCP-positive, n (%) | 0 (0) | 7 (50) | <0.0001 |
RF-positive, n (%) | 0 (0) | 6 (42.9) | <0.0001 |
TJC28 | 2.6 ± 2.0 | 7.9 ± 5.8 | 0.008 |
SJC28 | 2.7 ± 2.0 | 7.3 ± 5.3 | 0.011 |
CRP | 8.4 ± 8.1 | 23.0 ± 27.0 | 0.097 |
ESR | 16.4 ± 15.5 | 31.1 ± 22.4 | 0.075 |
VAS | 42.3 ± 32.1 | 46.9 ± 28.1 | 0.703 |
DAS28-ESR | 3.5 ± 1.0 | 4.9 ± 1.2 | 0.004 |
Radiographic erosions, n (%) | 0 (0) | 1 (7.1) | <0.0001 |